Arkema stock holds above EUR 59 as analysts see improving second half

Arkema stock (FR0010313833) is trading at EUR 59.70 on the Tradegate venue as of August 20, 2026, with the shares down 1.97% on the day but still positive year to date.

Recent market data show Arkema at EUR 59.10 to EUR 59.70 per share and indicate a year to date gain of between 15.69% and 16.65% for 2026, underscoring that the stock has recovered from earlier weakness even as it faces short term volatility.

Consensus data compiled by a leading equity research platform for Arkema as of August 20, 2026, point to an expected improvement in revenue and earnings over the coming quarters, with analysts highlighting stronger sales in the second half of the year.

Price action around the EUR 60 level

Intraday quotations on August 20, 2026, show Arkema changing hands around EUR 59.10 on a continental European trading venue, implying a 2.48% decline over the last five trading sessions and a modest 2.81% pullback from the start of the year.

A parallel Tradegate snapshot on August 20, 2026, reports Arkema at EUR 59.20, down 2.07% on the day, with the year to date performance standing at a gain of 15.69%; taken together, these figures suggest that recent profit taking has occurred against a backdrop of a double digit advance in 2026.

A separate analysis feed for Arkema on August 20, 2026, cites a previous close near EUR 60.38, reflecting a single session decline of 3.17% and a five day performance of minus 4.01%, which places the latest EUR 59 to EUR 60 readings just below that short term reference level.

One notable point for investors is that Arkema stock now trades slightly under the EUR 60 handle, implying a discount of roughly one euro to the recent 60.38 mark and highlighting that modest volatility can open tactical entry points even when the longer term trend remains constructive.

Analyst expectations and valuation context

The consensus overview for Arkema as of August 20, 2026, shows that equity analysts expect revenue growth and earnings expansion in the current fiscal year, supported by stronger sales in the second half as specialty materials demand normalizes from earlier softness.

Within that same consensus set, the year to date change cited for Arkema ranges from a gain of 16.65% on one real time quotation feed to 15.69% on another, indicating that the market has already priced in a significant portion of the expected improvement but still leaves room for further upside if the company delivers on its guidance.

Valuation ratios drawn from the August 20, 2026 data show Arkema quoted at EUR 60.38 at the most recent prior close with a 3.17% daily decline; when compared against the current EUR 59.70 level, this indicates that the stock has eased by EUR 0.68 from that prior mark, a move of just over one percent that keeps the shares within a narrow trading band.

For investors, the combination of a mid single digit five day decline, a double digit year to date gain, and an analyst narrative focused on stronger second half sales suggests that Arkema may be entering a consolidation phase in which short term volatility is shaped by expectations for upcoming quarterly releases.

Specialty materials portfolio and ketones exposure

Arkema is a global specialty materials producer with activities spanning advanced polymers, adhesives, coatings, and performance additives; the company also has exposure to the ketones segment, which is used in applications such as pharmaceutical solvents, specialty coatings, and industrial formulations.

A recent industry overview released on August 19, 2026, identified Arkema as one of the key participants in the global ketones market and projected that this market could reach USD 42.89 billion by 2035, driven by rising demand for solvents in pharmaceutical and other high growth end markets.

This positioning in ketones complements Arkema's broader portfolio of specialty materials, where its focus on high value added products and more sustainable formulations is intended to support margins over the cycle and to differentiate the company from bulk chemicals producers that are more exposed to commodity price swings.

In addition, Arkema's communications in mid August 2026 have highlighted that specialty products are under only mild pressure and that stronger sales are expected in the second half of the year, a message that aligns with analysts' expectations and provides a qualitative backdrop to the quantitative consensus figures.

Representative product: specialty ketone solvents

One representative product category within Arkema's portfolio is specialty ketone solvents, which are used by pharmaceutical companies and other industrial customers for applications that require precise solvency, controlled evaporation rates, and compatibility with sensitive active ingredients.

These specialty ketone solvents are typically marketed as part of Arkema's performance additives and solvent solutions range, offering tailored properties for niche uses such as high performance coatings, inks, and adhesives, where the solvent must balance strong dissolving power with regulatory and environmental requirements.

Because the ketones market is expected to grow steadily through 2035 on the back of pharmaceutical and fine chemicals demand, Arkema's involvement in this segment provides an additional lever for revenue growth and margin support over the medium term, complementing its other specialty materials businesses.

For end users, choosing Arkema's specialty ketone solvents can offer advantages in terms of formulation stability and process efficiency, which in turn can translate into higher productivity and lower total cost of ownership compared to more generic solvent alternatives.

Shares and current market level

Arkema shares trade on Euronext Paris under the home market listing associated with ISIN FR0010313833, with recent quote snapshots for August 20, 2026 showing prices in the EUR 59 to EUR 60 range and a single session decline of just under 2% on the Tradegate venue.

As of August 20, 2026, Arkema is quoted at EUR 59.70 on a widely followed market data portal, with the stock down 1.97% on the day but still up more than 15% year to date, indicating that the latest pullback remains modest within the context of the 2026 advance.

Fact box

Company: Arkema S.A.

ISIN: FR0010313833

Ticker: AKE

Exchange: Euronext Paris

Price (as of August 20, 2026, 9:31 a.m. ET): EUR 59.70

Sector / Industry: Chemicals / Specialty materials

Index membership: CAC 40